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Salmonella spp. is one of the main causes of foodborne illnesses in humans worldwide.
Consequently, great interest exists in reducing its impact on human health by lowering its
prevalence in the food chain. Antimicrobial formulations in the form of nanoparticles exert
bactericidal action due to their enhanced reactivity resultant from their high surface/volume
ratio. Silver nanoparticles (AgNPs) are known to be highly toxic to Gram-negative and
Gram-positive microorganisms, including multidrug resistant bacteria. However, few data
concerning their success against different Salmonella serovars are available. Aims of the
present study were to test the antimicrobial effectiveness of AgNPs, against Salmonella
Enteritidis, Hadar, and Senftenberg, and to investigate the causes of their different survival
abilities from a molecular point of view. Results showed an immediate, time-limited
and serovar-dependent reduction of bacterial viability. In the case of S. Senftenberg, the
reduction in numbers was observed for up to 4 h of incubation in the presence of 200 mg/l
of AgNPs; on the contrary, S. Enteritidis and S. Hadar resulted to be inhibited for up to
48 h. Reverse transcription and polymerase chain reaction experiments demonstrated
the constitutive expression of the plasmidic silver resistance determinant (SilB) by S.
Senftenberg, thus suggesting the importance of a cautious use of AgNPs.
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INTRODUCTION
Salmonella spp. is recognized as one of the main causes of
foodborne illnesses in humans worldwide. In 2011, a total of
95,548 conﬁrmed cases of human salmonellosis were reported
in the EU. Moreover, this microorganism is responsible for
the largest number of reported European food-borne outbreaks
(26.6% of all outbreaks; EFSA and ECDC, 2013). Two species
belong to the genus Salmonella: enterica and bongori. S. enter-
ica includes six subspecies and more than 2500 serovars, based
on the Kauffmann–White Le Minor scheme (Grimont and Weill,
2007), with different features in terms of resistance, infectiv-
ity, morbidity, and mortality. Even though Salmonella Enteritidis
and Typhimurium are the two most frequently isolated serovars
among humans (Foley et al., 2011), any serovar is considered
capable of causing gastrointestinal illness of varying severity in
humans.
Following these considerations, Salmonella nowadays repre-
sents a major challenge in animal health and food safety (EFSA
and ECDC, 2013); consequently great interest exists in reducing
its impact in human health by lowering its prevalence in the food
chain through a farm to fork approach. Different control mea-
sures have proven to be effective against Salmonella at farm level,
such as vaccination and proper hygiene management, whereas the
use of antimicrobials is forbidden according to EU Regulation
1177/2006, due to the risk of spread of antimicrobial resistance
(COMMISSION REGULATION (EC) No 1177/2006 of 1 August
2006, 2005).
Even thoughEURegulations on Salmonella control at farm level
focus the attention on a limited number of serovars, Regulation EC
2073/2005 on microbiological criteria for foodstuffs (COMMIS-
SIONREGULATION(EC)No2073/2005of 15November 2005on
microbiological criteria for foodstuffs, 2006) compels food busi-
ness operators to ensure the absence of Salmonella spp. in some
foods of animal origin. In cases of non-compliance with the food
safety criteria set out in the Regulation, the products shall be with-
drawn or recalled, which naturally poses serious problems for food
producers.
For these reasons, it is interesting to investigate the efﬁcacy
and applicability of new types of safe and effective biocidal com-
pounds. Silver has been used for centuries as an antimicrobial
(Silver et al., 2006) to ﬁght infections and prevent spoilage (Rai
et al., 2009), and it is well known that silver ions and silver-based
compounds are highly toxic to Gram-negative and Gram-positive
microorganisms (Bae et al., 2010; Fayaz et al., 2010; You et al.,
2011; Maillard and Hartemann, 2012). Previous studies have
shown that antimicrobial formulations in the form of nanopar-
ticles (NPs) could be used as effective bactericidal materials due to
their enhanced reactivity, resulting from their high surface/volume
ratio (Pal et al., 2007; Choi et al., 2008; Park et al., 2009). Par-
ticularly, silver in the form of NP (AgNP) is known to exhibit
strong biocidal effects on different bacterial species (Sondi and
Salopek-Sondi, 2004; Rai et al., 2009), including multidrug resis-
tant bacteria (Lara et al., 2010). It is generally accepted that free
silver ions, present or released from the nanomaterials, are able
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to bind cell membrane structures, destabilizing the membrane
potential and causing proton leakage (Gogoi et al., 2006; Maillard
and Hartemann, 2012). Even though the effectiveness of AgNPs
has been tested against the genus Salmonella (Chiao et al., 2012),
no data concerning different Salmonella serovars including those
which are of the greatest concern to humans, are available to
date. Furthermore, the use of silver as an antimicrobial has been
found to select resistance determinants (Pelgrift and Friedman,
2013), but little information is available on the possibility that the
same effect could also be exerted by AgNPs (Samberg et al., 2011).
Moreover, the presence of silver-resistance genes in environmental
Salmonella isolates needs to be established (Maillard and Harte-
mann, 2012) and the resistance toAgNPs of silver resistant bacteria
should be conﬁrmed. In fact, NPs have different physiochemi-
cal properties, compared to those of bulk material of the same
composition, which may possibly result in different toxicity mech-
anism(s) in biological systems (Nel et al., 2006). The exponential
increase in the use of AgNPs in recent years raises some concerns
about the risk associated with potential resistance in the bacterial
community (Maillard and Hartemann, 2012). Silver resistance in
food chain-associated bacteria could be a potential public health
problem since silver is a key component in several products (Gupta
et al., 1999) speciﬁcally devoted to food contact materials. How-
ever, data arising from scientiﬁc studies on the biological activity
of NPs are difﬁcult to interpret due to the peculiar chemical and
physical characteristics of these particles. Thus, it is fundamen-
tal to provide detailed characterization of any tested NPs, as this
would allow the scientiﬁc community to compare particles more
rationally.
Aims of the present study were to test the antimicrobial effec-
tiveness of silver in the form of NPs (AgNPs) against different
Salmonella serovars (Enteritidis, Hadar, Senftenberg) and to inves-
tigate the causes of their different survival ability, when identiﬁed,
from a molecular point of view.
MATERIALS AND METHODS
NANOPARTICLES AND CHEMICALS
Silver nanoparticles suspensions (code NM-300K batch n. 6051)
and their control dispersant medium were purchased from
LGC Standards (UK). These NPs are included in the Joint
Research Center Nanomaterials Repository, are approved within
the OECD WPMN (Working Party on Manufactured Nanoma-
terials) international testing program as selected representative
reference nanomaterial (OECD Paris, 2010), and are delivered
in aqueous solution containing 4% of polyoxyethylene glyc-
erol trioleate and polyoxyethylene sorbitan mono-laurate (Tween
20). Silver nitrate (AgNO3) was purchased from Sigma-Aldrich
(USA).
BACTERIAL STRAINS
Bacterial wild strains, S. Enteritidis (3546/6 2012) isolated from
an environmental swab of a layer hens’ pen, S. Hadar (2507/5
2009) isolated from a broiler chicken cloacal swab and S. Sen-
ftenberg (3014/3 2012) isolated from an environmental swab
of a layer hens’ pen, were obtained from the collection of
pathogenic microorganisms of the OIE Reference Laboratory for
Salmonellosis (Istituto Zooproﬁlattico Sperimentale delleVenezie,
Legnaro, Italy). Salmonella strains were stored in MicrobankTM
(Pro-Lab Diagnostics, USA) at −80◦C until needed. Kleb-
siella pneumoniae clone ST258 (García-Fernández et al., 2012),
used as positive control, was kindly provided by Dr Alessan-
dra Carattoli at Istituto Superiore di Sanità, Rome, Italy. The
stock cultures were subcultured on tryptone agar (TA) slants
at 4◦C, and Salmonella serovars were conﬁrmed by serotyp-
ing according to Grimont and Weill (2007), transferred to
15 ml of Mueller-Hinton broth (MHB) and incubated at 37◦C
overnight.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
Salmonella strains were tested for susceptibility to antimicro-
bials (Table 1) using a commercial microdilution test (Sensititre®
Salmonella plate – EUMVS2) according to the manufacturer’s
recommendations. The results were read visually after 24 h of
incubation at 37◦C, and the minimum inhibitory concentration
(MIC)was deﬁned as the lowest concentrationof the antimicrobial
that completely inhibited visible growth.
AgNPs CHEMICAL PURITY
Chemical purity of AgNPs was evaluated by inductively coupled
plasmamass spectrometry (ICP-MS,NexION300DPerkinElmer).
In order to obtain a suitable concentration for ICP-MS anal-
ysis, a diluted solution of AgNPs was prepared (105 mg/kg),
then microwave-assisted digestion (Mars5, CEM) was performed
on triplicate samples (average weight: 0.200 g) according to
the method suggested by Klein et al. (2011). Accurate control
of contamination was performed by processing four method
blanks. A semi-quantitative analysis was carried out to gain
a general evaluation of the impurities, and then the most
relevant elements were quantiﬁed by an external calibration
method.
Table 1 | Salmonella serovars used and their susceptibility to
antibiotics, described as minimum inhibitory concentration
(MIC mg/l).
MIC (mg/l) S. Enteritidis S. Hadar S. Senftenberg
Sulfamethoxazole 64 >1.024 >1.024
Gentamicin 0.50 1 0.50
Ciproﬂoxacin 0.015 0.5 0.25
Ampicillin 0.5 >32 0.25
Cefotaxime 0.06 0.12 0.12
Ceftazidime 0.25 0.50 0.25
Tetracycline 1 32 1
Streptomycin 2 64 16
Trimethoprim 0.5 0.5 0.5
Chloramphenicol 4 8 8
Colistin 2 2 2
Florfenicol 4 4 8
Kanamycin 4 4 4
Nalidixic acid 4 >64 >64
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SIZE AND MORPHOLOGY OF AgNPs
AgNPs morphology, size and stability over time in the culture
medium, were analyzed by transmission electron microscopy
(TEM) and dynamic light scattering (DLS). TEM analysis was
performed with a Fei Tecnai 12 G2 microscope operated at 120 kV.
NPs were suspended in ultrapure water at 100 mg/l, deposited
on carbon coated copper grids and left to dry overnight. Micro-
graphs were recorded on a side mounted Olympus Morada CCD
camera. Size distribution analysis was performed using a semi-
automatic method implemented in ImageJ software (Schneider
et al., 2012). The analysis involved particle segmentation and area
determination. The diameter of each particle was estimated from
the particle area assuming a perfectly circular particle. For DLS
analyses, AgNPs 50 mg/l suspension in ultrapure water was ana-
lyzed with a Malvern Zetasizer Nano ZS DLS instrument operated
in backscattering mode. Measurements were carried out at 23◦C
and were conducted in triplicate to check for sedimentation and
solution stability.
AgNPs SUSCEPTIBILITY ASSAY
The effectiveness of AgNPs as an antimicrobial was determined
by assaying the number of culturable bacterial cells which formed
colonies after incubation in the presence of AgNPs or AgNO3. Sil-
ver nitrate was used to investigate the effect of silver ions. MHB
was used as culture medium with the objective of obtaining a
good compromise between Salmonella spp. growth and NPs sta-
bility, given that this is a quite simple and non-selective liquid
medium, speciﬁcally designed for susceptibility studies and having
the minimum requirements for bacteria growth.
Brieﬂy, overnight Salmonella inocula, grown in MHB to an OD
A600 = 0.3 [108 colony-forming units (CFUs)/ml], were incubated
in an orbital shaker at 200 rpm at 37◦C for 30 min, 1, 2, 4, 24, 48,
and 72 h in the presence of AgNPs (200, 150, 100, 50, 20 mg/l) or
AgNO3 (20, 15, 10 mg/l). Two controls were included: one ﬂask
containing NPs and nutrient media devoid of inoculum, and one
ﬂask containing inoculum and nutrient media, devoid of NPs or
silver nitrate.
The high rotary shaking speed was selected to minimize the
aggregation and settlement of the NPs over the incubation period.
At the indicated time points (30 min, 1, 2, 4, 24, 48, and 72 h)
100 μl aliquots of serial 10-fold dilutions of bacterial cultures in
MHB were plated on xylose lysine tergitol 4 (XLT4) agar plates.
Colonieswere counted after incubation at 37◦C for 24h and counts
expressed as CFU/ml. All counts were checked also after 48 h
in order to exclude the presence of colonies possibly sub-lethally
injured (but not killed) by AgNPs.
Each of the experiments was performed in triplicate and the
CFU counts were normalized and then summarized as mean
values and standard deviations (SDs). For statistical purposes a
value of 300 colonies was assigned to plates on which more than
300 colonies were observed (according to ISO 7218/2007). The
AgNPs and AgNO3 concentrations causing inhibitory effects were
determined based on the absence of colonies on the agar plates.
SILVER RESISTANCE MOLECULAR TESTING
Bacterial total DNA was extracted by boiling extraction method.
Brieﬂy, one single colony of each serovar growing on solid media
was resuspended in 100 μl of sterile molecular biology-grade
water (Eppendorf, Hamburg, Germany) in a microcentrifuge
tube, subjected to boiling at 100◦C for 10 min, cooled on
ice, and centrifuged at 15,000 g for 10 s before being stored
at −20◦C. Total DNA was quantiﬁed spectrophotometrically
by using a SmartSpecTM Plus spectrophotometer (Bio-Rad Life
Science, USA) and aliquoted.
The plasmidic DNA fraction was extracted from pelleted cells
using theQIAprep SpinMiniprepKit (Qiagen). The concentration
and purity of plasmid DNA was determined spectrophotometri-
cally by measuring the A260nm/A280nm ratio.
REVERSE TRANSCRIPTION AND POLYMERASE CHAIN REACTION
Overnight S. Senftenberg inocula, grown on MHB to an OD
A600 = 0.3 (108 CFU/ml), were incubated in an orbital shaker
at 200 rpm at 37◦C for 4 and 24 h in the presence of AgNPs (0 and
200 mg/l) or AgNO3 (0 and 20 mg/l). Cell cultures were pelleted
and total RNA isolated using the NucliSENS® kit (Biomérieux,
Italia SPA). The concentration and purity of RNA was determined
spectrophotometrically by measuring the A260nm/A280nm
ratio.
For cDNA synthesis, the Enhanced Avian reverse transcrip-
tion and polymerase chain reaction (RT-PCR) kit (Sigma-Aldrich,
USA) was used. Total RNA (5 μg) was incubated in DEPC-
treated water with 2.5 μM oligodT, preheated at 70◦C for 10 min,
and incubated in the presence of avian reverse transcriptase at
42◦C for 1 h following the conditions recommended by the
manufacturer.
PCR samples were prepared by adding 5 μl of 4 ng/μl DNA
template to a reaction mix containing 200 μM dNTPs, 0.4 μM of
each primer, 1× polymerase buffer, 2 mM MgCl2 and 1.5 U of
AmpliTaq Gold (Applied Biosystem, USA) DNA polymerase; the
reaction volume was made up to 50 μl with nuclease-free water.
PCRs were carried out in a GeneAmp PCR System 9700 (Applied
Biosystem, USA) using the following PCR protocol: 5 min at 95◦C
followed by 30 cycles of 95◦C for 30s, 57◦C for 30s, and 72◦C for
30 s. A ﬁnal elongation step was performed at 72◦C for 5 min. SilB
gene primers sequences, SilB forward (CAAAGAACAGCGCGT-
GATTA) and SilB reverse (GCTCAGACATTGCTGGCATA), were
designed according to Woods et al. (2009).
PCR products were resolved in 1% agarose Tris acetate-EDTA
(TAE) gel, stained with ethidium bromide (Sigma, Dorset, UK),
electrophoresed for 1 h at 70 V/cm and visualized with a Bio-Rad
Gel doc system. A Perfect DNA Markers (EMD, Millipore, USA),




With the use of transmission electron microscope, AgNPs sus-
pension appeared as a mixture of heterogeneous particles by
size and shape (Figure 1A). Most particles were spherical, but
the sporadic presence of regular polygonal particles was also
observed. Particle size distribution (obtained from 8872 particles)
showed two major populations, with median (±MAD) diameters
of 6(±2) and 18(±2) nm (with ﬁrst and third quartiles at 5–8
and 16–19 nm, respectively; Figure 1B). Particle size distribution
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FIGURE 1 | RepresentativeTEM micrograph (A) and particle size distribution obtained fromTEM data (B) of NM-300K silver nanoparticles dispersed
in water. Scale bar equals 100 nm.
fromDLS data agreedwith TEMdata showing a polydisperse sam-
ple (PDI = 0.485) with particles having diameters between 5 and
>500 nm with the most frequent population having diameters
between 6 and 20 nm (Figure 2). No differences were observed in
the AgNPs size and shape after incubation in the presence of the
culture medium MHB with no aggregates identiﬁed at any time
(data not shown).
ICP-MS analysis to evaluate the chemical purity of the AgNPs
showed that the contaminant elements (V, Al, Fe, Mg, Si)
detected in the samples were comparable with those in the
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FIGURE 2 | Intensity-based particle size distribution of an aqueous
suspension of NM-300K silver nanoparticles obtained from DLS
analysis.
blanks. Therefore, these contaminating elements were consid-
ered as negligible for the purpose of the present study (data not
shown).
Salmonella STRAINS
Bacterial strains were chosen taking into account their impor-
tance for public health, as in the case of S. Enteritidis and
S. Hadar (EFSA, 2008) and for their ability to adapt to unfa-
vorable chemical–physical environments, as is the case of S.
Senftenberg (Ng et al., 1969; Broennum Pedersen et al., 2008).
Salmonella strains antimicrobial resistances have been described in
Table 1.
AgNPs SUSCEPTIBILITY ASSAY
To compare the antibacterial effect of AgNPs on the Salmonella
serovars and to assess the duration of this effect over time, a cell
culturability assay in liquid culture was carried out. Equal num-
bers (approximately 1 × 108 CFU/m) of CFUs of S. Enteritidis, S.
Hadar, and S. Senftenberg were incubated individually with differ-
ent concentrations of AgNPs or AgNO3. At different time points,
aliquots were removed and plated onto selective medium to count
culturable cells.
As shown in Figure 3, AgNPs treatment reduced Salmonella
counts to different extents depending on the serotype. The effect
was proportional to the dose with 200 mg/l being the most effec-
tive, and 20 mg/l the least effective for all tested Salmonella
serovars. Moreover, a strong difference in the recovery from the
antibacterial effect was observed as S. Enteritidis cells never recov-
ered, even after 72 h of incubation with the maximum AgNPs
tested concentration (Figure 3E). S. Hadar clearly displayed a
total recovery at 72 h (Figure 3C) while S. Senftenberg was inhib-
ited by AgNPs only for 4 h (Figure 3A). When Salmonella strains
were incubated in the presence of the minimum concentration of
AgNPs (20 mg/l), their recovery was variable, as AgNPs inhibited
S. Hadar to a lesser extent than S. Enteritidis and S. Senftenberg
(Figures 3A,C,E).
However, strong differences in the recovery patterns were
observed between the three tested serovars. As shown in Figure 3,
AgNPs were the most effective against S. Enteritidis (Figure 3E),
with a noticeable reduction in bacterial numbers after just 1 h of
exposure to a dose of 50mg/l. In the presence of 100mg/l of AgNPs
the inhibition continued after 72 h of exposure. In the case of S.
Hadar (Figure 3C), although AgNPs displayed effectiveness at the
same doses that were effective for S. Enteritidis, complete recov-
ery from the antibacterial effects of AgNPs was observed between
1 and 72 h of exposure, depending on the dose. AgNPs were
not effective against S. Senftenberg (Figure 3A), which started to
grow between 1 and 4 h of exposure to AgNPs, depending on the
dose.
A comparable dose-effect and a parallel trend of reduction in
bacterial counts and recovery from the antibacterial effect was
observed in the presence of AgNO3 but with one order of mag-
nitude of difference, for each of the tested Salmonella serovars
(Figures 3B,D,F).
AgNPs RESISTANCE OF Salmonella STRAINS
The selective loss of antimicrobial effectiveness, depending on the
Salmonella serovar, consented to hypothesize the presence of a
speciﬁc mechanism of resistance.
To test this hypothesis the three Salmonella serotypes, Sen-
ftenberg, Hadar, and Enteritidis, were screened for the presence
of the SilB gene, which is one of the most plausible resistant
determinants found to be involved in both silver and copper
resistance pathway of many Gram-negative bacteria (Silver and
Phung, 2005) and can be of either plasmidic or cromosomic ori-
gin (Silver, 2003; Silver and Phung, 2005). As shown in Figure 4A,
one PCR product of the size of 233 bp, expected for SilB frag-
ment ampliﬁcation, was ampliﬁed from total DNA extract only
in the case of S. Senftenberg (Figure 4A, lane 2). No ampliﬁca-
tion products were observed in the case of the other investigated
Salmonella serovars (Figure 4A, lanes 3 and 4) and this is consis-
tent with the fact that only S. Senftenberg showed a silver resistant
phenotype in the culturability assay. K. pneumoniae strain, clone
ST258, used as positive control (Figure 4A, lane 1), was previously
described as carrying the pKPN-IT (JN233704) plasmid, highly
related to plasmid pKPN3 identiﬁed in K. pneumoniae and con-
ferring resistance to arsenic, copper, and silver (García-Fernández
et al., 2012).
To verify the plasmidic origin of the investigated SilB gene,
plasmidic DNA was isolated and screened by PCR for the presence
of SilB gene. The result, shown in Figure 4B, clearly indicates that
the resistance gene was positioned on the plasmidic portion of
DNA in the case of S. Senftenberg (Figure 4B, lane 2) as it was
for K. pneumoniae strain, clone ST258, used as positive control
(Figure 4B, lane 1).
In order to test the expression of SilB gene in the resistant S.
Senftenberg strain, in presence and absence of AgNPs or AgNO3,
qualitative RT-PCR experiments from total RNA extract were car-
ried out. K. pneumoniae strain, clone ST258, was used as control.
As indicated in Figure 5, SilB is constitutively expressed by S. Sen-
ftenberg strain both in the presence of AgNPs orAgNO3 and in the
absence of any silver forms with K. pneumoniae strain displaying
the same expression proﬁle (Figure 5).
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FIGURE 3 | Growth curves of Salmonella Senftenberg (A,B), Salmonella Hadar (C,D), and Salmonella Enteritidis (E,F), in the presence of different
doses of AgNPs (left side) or AgNO3 (right side).
DISCUSSION
The continued evolution of bacteria strains displaying resistance
to multiple antibiotics, has prompted the scientiﬁc community
as well as the food business operators to look for antimicro-
bial alternatives. Thus silver, which is commonly considered a
broad-spectrum antimicrobial agent, could represent a suitable
option, especially in its nanoform (Silver et al., 2006). There is
circumstantial evidence that these particles have good antimi-
crobial activity; however, the exact way in which they exert
this activity is still speculative (Pelgrift and Friedman, 2013).
AgNPs have shown antimicrobial activity against a wide array of
microbes, probably due to their multiple mechanisms of antimi-
crobial action, including activity against drug-resistant bacteria,
fungi, and viruses (Sondi and Salopek-Sondi, 2004; Pal et al.,
2007; Choi et al., 2008; Fayaz et al., 2010; Lara et al., 2010; Sam-
berg et al., 2011; You et al., 2011). Nonetheless the present study
demonstrates that AgNPs can be effective as an antimicrobial
even in the case of Salmonella, but that its success is strongly
Salmonella strain-dependent, since great differences in terms of
effective dose and time of action were observed for the three
investigated serovars (S. Enteritidis, S. Hadar, and S. Senften-
berg). This is probably due to many factors strictly related to
the genetic features of each strain, including the presence of spe-
ciﬁc genetic determinants of resistance, as demonstrated in the
case of S. Senftenberg, which speciﬁcally expressed the resistance
gene SilB. The antimicrobial resistances for the tested antibiotics,
displayed in Table 1, do not followed the same pattern of sil-
ver resistance since S. Hadar appeared in general more resistant
than S. Senftenberg. Silver resistance has been reported in bacteria
isolated from both clinical (Carr and Rosenkranz, 1975; Annear
et al., 1976; Hendry and Stewart, 1979; Markowitz et al., 1983;
Klasen, 2000) and environmental (Belly and Kydd, 1982; Haefeli
et al., 1984; Grewal and Tiwari, 1990; Choudhury and Kumar,
1998) settings. The resistance mechanisms include altered cell
membranes that decrease uptake of Ag and efﬂux pumps that
pump Ag out of the cell (Silver and Phung, 2005). Among the
determinants of silver resistance, SilB was originally found on
Salmonella plasmid pMG101 (Mchugh et al., 1975) and encodes
resistances to Ag+, Hg2+, and tellurite, as well as to several antibi-
otics (Mchugh et al., 1975; Gupta et al., 1999). Salmonella and
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FIGURE 4 | (A) One percent agarose gel showing the PCR product of SilB
ampliﬁcation from total DNA of Klebsiella pneumoniae, clone ST258 (lane 1),
Salmonella Senftenberg (lane 2), Salmonella Hadar (lane 3), Salmonella
Enteritidis (lane 4). In the lane 5 was run the negative control (DNA template
replaced by sterile water). (B) One percent agarose gel showing the PCR
product of SilB ampliﬁcation from the plasmidic DNA fraction of Klebsiella
pneumoniae, clone ST258 (lane 1) and Salmonella Senftenberg (lane 2). The
asterisks indicate the 233 bp PCR product expected for SilB fragment
ampliﬁcation. MW indicates the Perfect DNA Markers (EMD, Millipore, USA),
0.05–10 kb ladder.
FIGURE 5 | RT-PCR analysis. One percent agarose gel showing DNA bands
originating from PCR ampliﬁcation experiments referring to Klebsiella
pneumoniae, clone ST258 (K) and Salmonella Senftenberg (S). The asterisk
indicates the 233 bp PCR product expected for SilB fragment ampliﬁcation.
MW indicates the Perfect DNA Markers (EMD, Millipore, USA), 0.05–10 kb
ladder.
Escherichia coli have, in addition, a related chromosomalAg+ resis-
tance determinant (Gupta et al., 2001; Franke et al., 2003; Silver,
2003).
However, silver export from Gram-negative bacterial cells
might also be determined by other efﬂux systems, as the Agr and
CusCBAprotein complexes (Franke et al., 2003) that can bind both
copper and silver. Moreover P-type ATPases and cation diffusion
facilitators that export surplus metals from the cytoplasm can be
involved in metal resistance. These determinants are not only nec-
essary for resistance to toxic metal ions such, but also needed to
tolerate at high concentrations some metals that are essential at
low concentrations (Nies and Herzberg, 2013) as in the case of
Salmonella spp. CopA and GolT, P-type ATPases (Espariz et al.,
2007; Pontel et al., 2007; Osman et al., 2010, 2013).
The silver resistance conferred by plasmid pMG101 contains
nine genes (Gupta et al., 1999; Silver, 2003) coding for one efﬂux
ATPase (SilP), two metal-binding proteins (SilF and SilE), and one
cation/proton antiporter (SilCBA; Gupta et al., 1999; Silver et al.,
2006). All these proteins are supposed to work in a synergistic
way as SilP release Ag+ in the periplasmic space, SilF functions
as a Ag+ carrier from its periplasmic site of release by SilP to the
periplasmic site of uptake by SilA as part of the SilCBA complex,
which drives Ag+ out from the bacterial cell (Silver et al., 2006).
Within the SilCBA complex, SilA is an inner membrane cation
pump protein, SilC is an outer membrane protein and SilB is a
periplasmic membrane fusion protein that spans the inner and
outer membrane and contacts both SilA and SilC (Gupta et al.,
1999; Silver et al., 2006). Due to its central role in the unique Ag+
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external efﬂux system, SilB could represent a good marker for the
presence of the silver resistance pathway. Since silver has a broad
range of actions on cellular processes, silver resistance does not
seem to spread as antibiotic resistance does, andwhich, in contrast,
speciﬁcally targets one process. In spite of this, plasmid-encoded
silver resistance is a matter of concern, since plasmid-mediated
metallic salt resistance has been associated with co-resistance to
chemotherapeutic antibiotics (Mchugh et al., 1975; Gupta et al.,
1999), and furthermore, the fact that it is a plasmid-mediated resis-
tance means it has potential to easily spread among the bacterial
community, both commensal and pathogenic (Szmolka and Nagy,
2013). In addition, silver resistancemight persist in the clinical set-
ting (Gupta et al., 2001) posing serious threats in consideration of
the widespread use of silver in hospital devices, environmental
surfaces and disinfection products.
Silver-resistance genes have been assumed to be expressed in
response to long-term exposure to Ag, while expression should
be lost in the absence of Ag (Lara et al., 2010; Knetsch and Koole,
2011). This could suggest a decrease of evolutionary ﬁtness in
bacteria carrying silver resistance genes, due to the genes being per-
manently carried and copied, but expressed only in the presence
of Ag (Pelgrift and Friedman, 2013). However, gene expression
experiments reported in this study clearly demonstrated the con-
stitutive expression of SilB gene, both in the presence and in the
absence of silver, in both its tested forms: “nano” or ionic. More-
over, S. Senftenberg tested in this study was isolated from samples
belonging to the food chain where silver is not common as con-
taminant and only trace levels are expected to be present (Millour
et al., 2012).
CONCLUSION
The results obtained from the AgNPs susceptibility assays demon-
strate that AgNPs were effective as antibacterial against all treated
Salmonella strains only over a short period of time, thus suggest-
ing that the pathogen’s ability to survive in the presence of AgNPs
could be a challenge for the proposed application.
Moreover the presence of the plasmid containing the SilB
gene in the resistant strain S. Senftenberg entails that it could be
acquired under environmental selective pressure and transferred
to other bacterial species. This is of particular importance in the
ﬁeld of food safety because silver compounds are used to sanitize
food production plants in order to eliminate pathogens that are
considered to be relevant for public health, as the three investigated
Salmonella serovars.
Furthermore, the greater activity of AgNO3 compared to that
of AgNPs suggests that ions are the more effective elements exert-
ing antibacterial activity. However, further evidence is needed to
support this hypothesis.
Nevertheless, it is important to emphasize that the present
study took into consideration only one type of AgNP; thus the
results here discussed cannot be completely generalized due to the
broad variability of NP biological activities that depend not only
on their chemical form but also on the speciﬁc shape and dimen-
sional range. Smaller sizedAgNPs (<10 nm)were demonstrated to
have higher antimicrobial activity than larger particles (Xu et al.,
2004; Gogoi et al., 2006). In addition, Pal et al. (2007), demon-
strated that triangular shaped particles of silver were more active
as antimicrobials than rods and spherical particles (Pal et al., 2007)
and in a study by Lok et al. (2007) oxidized particles were shown
to exert different antimicrobial properties (Lok et al., 2007). This
indicates that the surface area of the particles is important for their
activity, as Ag+ release, the determining factor for antimicrobial
activity, might be dependent on the surface area. Therefore, the
inhibitory or antibacterial effects AgNPs have on Salmonella must
be evaluated a case-by-case basis in the future.
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